Head-to-head · WeighScore
Lttl vs Optimized Health
By GLP-1 ScorecardUpdated
Score comparison
Optimized Health has the higher recorded score — 67.2/100 to 63.5/100.
Optimized Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Optimized Health is a concierge medical weight loss and hormone clinic offering clinician-supervised GLP-1 programs with compounded semaglutide and tirzepatide, plus oral options like phentermine.
Before you choose
Before comparing the headline prices, the Lttl review and the Optimized Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Lttl vs Strut Health and Mevo Health vs Optimized Health compare each of them with another graded program, and the list of alternatives to Lttl ranks the programs closest to Lttl on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Lttl | Optimized Health |
|---|---|---|
| WeighScore | 63.5/100 | 67.2/100 |
| Grade | C | C |
| Site position | #203 | #181 |
| Semaglutide | $99/mo monthly auto-refill; $89/mo equivalent billed $1,068 annually (confirm supply/renewal) | $200/mo (starting dose, compounded) |
| Tirzepatide | $149/mo monthly auto-refill; $139/mo equivalent billed $1,668 annually (confirm supply/renewal) | $250/mo (starting dose, compounded) |
| Coverage | Provider claims 50 states + DC; treatment availability varies | 5 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #203 · C
Strengths
- Public ordinary monthly injection rates of $99 semaglutide and $149 tirzepatide, with longer-plan charges disclosed separately
- The plan selector identifies supply lengths, including four weeks for monthly auto-refill and 52 weeks annually
- Four possible dispensing pharmacies are named in the terms, without an individual assignment established
- Microdose injection and oral-tablet selector entries provide additional options to discuss with a clinician; availability and clinical suitability require confirmation
What to consider
- Monthly, quarterly and six-month supply labels do not align with calendar-month language; confirm actual refill and debit intervals
- Medical-rejection refund language conflicts with consultation-fee retention wording
- Terms use medical intake as a nonrefund boundary, while support uses pharmacy processing/shipping; refund deadlines also differ
- The assigned treating practice, prescriber and actual dispensing location remain unestablished
- Branded-service exceptions are described, but no available brand-specific prescription or price was established
- A 48-hour shipping headline differs from the policy estimate of two to five business days processing plus three to seven in transit
Strengths
- Fully transparent pricing published on the website
- Semaglutide from $200/mo and tirzepatide from $250/mo
- Lab panels included with clinician-supervised dosing
- LegitScript certified clinic
- Lead PA-C with over a decade in obesity medicine
What to consider
- Telehealth limited to MO, IA, KS, UT, and WA
- Compounded GLP-1 only, not brand-name
- No insurance billing (cash-pay)
- PA-led rather than MD/DO-led
Featured provider
Lttl
Lttl scores 63.5/100 (C). Lttl publishes monthly and longer compounded-injection offers plus a low-dose and oral menu; compare the actual charge and supply interval because annual equivalents and four-week labels describe different commitments.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.